Heartbeam Q1 2026 Earnings Narrowed Loss Beats Expectations as Cardiac Monitoring Platform Advances ITRN Q4 2025 Earnings EPS Beats Estimates Stock Rises 316 Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues SFIX Q1 2026 Earnings Surprising EPS Beat Masks Uncertainty as Revenue Details Remain Unclear TELO Q4 2025 Earnings WiderthanExpected Loss Stings as PreRevenue Biotech Focuses on Pipeline ONL Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines